DEINOVE: SUCCESSFUL CAPITAL INCREASE OF € 8.5 MILLION

June 15, 2018
DEINOBIOTICS/DEINOVE

Montpellier, 15 June 2018 (08:30 am CEST) – DEINOVE (Euronext Growth Paris: ALDEI), a biotech company that discovers, develops, and produces high-value compounds from rare bacteria, announces today the success of its capital increase reserved for one category of beneficiaries, performed via the accelerated building of an order book.

Press Release available here: